Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Cancer Research|August 1, 1997
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxiaE O Aboagye, R J Maxwell, A B Kelson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 5, 2020
Outbreak of multi-drug-resistant (MDR) Shigella flexneri in northern Australia due to an endemic regional clone acquiring an IncFII plasmidChristine J D Guglielmino, Asha Kakkanat, Brian M Forde, et al.
BMC Microbiology|April 13, 2022
Standard rectal swabs as a surrogate sample for gut microbiome monitoring in intensive careSanmarié Schlebusch, Rikki M A Graham, Amy V Jennison, et al.
International Journal of Medical Microbiology : IJMM|October 19, 2010
Biological functions of GCS3, a novel plasminogen-binding protein of Streptococcus dysgalactiae ssp. equisimilisRené Bergmann, Katrin Dinkla, D Patric Nitsche-Schmitz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trialM A Graham, S Senan, H Robin, et al.
Cancer Research|February 1, 1993
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusionD Bissett, A Setanoians, J Cassidy, et al.
Therapeutic Advances in Infectious Disease|June 9, 2025
Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trialAdam G Stewart, Patrick N A Harris, Rikki M A Graham, et al.
Microbiology Resource Announcements|November 30, 2022
Genomes of Vibrio cholerae O1 Serotype Ogawa Associated with Current Cholera Activity in PakistanEby M Sim, Elena Martinez, Grace A Blackwell, et al.
Cancer Research|October 1, 1989
Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine)I R Judson, A H Calvert, C J Rutty, et al.
Pageof 11